Pharmaceuticals company Boehringer Ingelheim expects to invest more than $50 million in its Xochimilco plant in Mexico, with the aim of increasing and improving production by its diabetes segment in the next three years. The company also plans to invest $25 million in its veterinary products plant in Guadalajara, with an expansion to be completed in 2021.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
